✦ LIBER ✦

The Presence of Polyomavirus in Non-Melanoma Skin Cancer in Organ Transplant Recipients Is Rare

✍ Scribed by Ridd, Katie; Yu, Siegrid; Bastian, Boris C

Book ID: 109875187
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 100 KB
Volume: 129
Category: Article
ISSN: 0022-202X
DOI: 10.1038/jid.2008.215

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of Non-Melanoma Skin Cancer i

Management of Non-Melanoma Skin Cancer in Immunocompromised Solid Organ Transplant Recipients

✍ Bangash, Haider K.; Colegio, Oscar R. 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 406 KB

Advances in the Chemoprevention of Non-m

Advances in the Chemoprevention of Non-melanoma Skin Cancer in High-Risk Organ Transplant Recipients

✍ Mary H. Lien; Neil Alan Fenske; L. Frank Glass 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Melanoma in Solid Organ Transplant Recip

Melanoma in Solid Organ Transplant Recipients

✍ F. O. Zwald; L. J. Christenson; E. M. Billingsley; N. C. Zeitouni; D. Ratner; J. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Immunosuppression and risk of non-melano

Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients

✍ Mary T Glover; Jonathan J Deeks; Martin J Raftery; John Cunningham; Irene M Leig 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 146 KB

Role of radiotherapy in the management o

Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers

✍ Veness, MJ ;Harris, D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB

Acitretin for chemoprevention of non-mel

Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients

✍ Renu George; Warren Weightman; Graeme R Russ; Kym M Bannister; Timothy H Mathew 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

## SUMMARY A prospective, open randomized crossover trial was conducted to evaluate the efficacy of acitretin for chemoprevention of squamous cell carcinomas and basal cell carcinomas in renal allograft recipients. Analysis was performed according to the intention‐to treat principle. Twenty‐three p